104 results
Page 4 of 6
425
EX-99.1
b70x6nqyceon3
23 Jul 08
Business combination disclosure
12:00am
425
EX-2.1
mxdmkrxqudazm
18 Jul 08
Business combination disclosure
12:00am
6-K
EX-2
z23fa9pqtqjz7y96u
18 Jul 08
Report of Foreign Private Issuer
12:00am
6-K
85f64kp 9u7b
12 May 08
Teva to Present at the Bank of America Health Care Conference
12:00am
6-K
0nj7cxg arv
13 Feb 07
Teva Reports Fourth Quarter and Full Year 2006 Results
12:00am
6-K
ruxhz
13 Nov 06
Current report (foreign)
12:00am
6-K
wkfykg
14 Aug 06
Current report (foreign)
12:00am
6-K
p15d8 2tw5h2kir93b
27 Jul 06
Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-remitting Multiple Sclerosis
12:00am
6-K
f82hvkwgdm9oionw0uhe
15 May 06
Current report (foreign)
12:00am
6-K
x2sln bl5nj
6 Apr 06
Notice of Annual Meeting of Shareholders - Amendment
12:00am
6-K
u19 988crlouqnx9x
3 Apr 06
Proxy Statement
12:00am
6-K
5gwm9d51l j7ygot7170
28 Feb 06
Teva Reports Record Sales and Net Income for the Fourth Quarter and Full Year 2005
12:00am
F-3ASR
897e dn28
30 Jan 06
Automatic shelf registration (foreign)
12:00am
424B5
5iy72ipk6cp0f
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
j6yzusp4prbfqk27d
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
7eh64t7xrecyer02i
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
m9y01agz3vtk3f9
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
wthzr2n5w72s r3cy
26 Jan 06
Prospectus supplement for primary offering
12:00am